Extendicare Reports 15% Q2 Growth, Completes Major LTC Acquisitions

Extendicare Inc., a leading Canadian healthcare provider specializing in long-term and home healthcare, reported robust Q2 2025 financial results, reflecting strong revenue and earnings growth driven by strategic acquisitions and demographic trends. The company’s revenue rose 10% year-over-year to CAD 383.45 million, while net earnings increased to CAD 31.92 million, surpassing analyst expectations in earnings per share with CAD 0.373 reported. Adjusted EBITDA grew by 15.4%, fueled by the acquisition of nine long-term care homes from Revera and the home healthcare provider Closing the Gap, which added significant operating income and service hours. Despite slightly missing revenue forecasts, Extendicare maintains a positive outlook supported by recent acquisitions, an increased CAD 375 million credit facility, and favorable government policies aimed at long-term care redevelopment. The company’s CEO emphasized the importance of aligning with megatrends such as an aging population and the shift to home-based care, which underpin sustained demand and long-term growth potential. Analysts view the stock as a hold, noting both operational strengths and risks related to financial leverage and market conditions.